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Abstract
Nonlinear mixed effects models represent a powerful tool to simultaneously analyze
data from several individuals. In this study a compartmental model of leucine ki-
netics is examined and extended with a stochastic differential equation to model
non-steady state concentrations of free leucine in the plasma. Data obtained from
tracer/tracee experiments for a group of healthy control individuals and a group of
individuals suffering from diabetes mellitus type 2 are analyzed. We find that the
interindividual variation of the model parameters is much smaller for the nonlinear
mixed effects models, compared to traditional estimates obtained from each indi-
vidual separately. Using the mixed effects approach, the population parameters are
estimated well also when only half of the data are used for each individual. For a
typical individual the amount of free leucine is predicted to vary with a standard
deviation of 8.9% around a mean value during the experiment. Moreover, leucine
degradation and protein uptake of leucine is smaller, proteolysis larger, and the
amount of free leucine in the body is much larger for the diabetic individuals than
the control individuals. In conclusion nonlinear mixed effects models offers improved
estimates for model parameters in complex models based on tracer/tracee data and
may be a suitable tool to reduce data sampling in clinical studies.
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1 Introduction
The powerful combination of nonlinear mixed effects (NLME) models and stochastic dif-
ferential equations (SDEs) has lately received increasing attention (Donnet et al., 2010;
Picchini and Ditlevsen, 2010), with many applications in the area of pharmacokinetic/pharmacodynamic
modelling (Overgaard et al., 2005; Møller et al., 2010).
Nonlinear mixed effects models are used to study population characteristics when data
have been gathered for multiple individuals governed by the same intraindividual (within
individuals) mechanisms (see, e.g., Davidian and Giltinan, 1995, 2003; Olofsen et al., 2004;
Pillai et al., 2005; Pinheiro and Bates, 2000; Sheiner and Beal, 1980). NLME models are
hierarchical in structure and take population behaviour and individual properties into
account simultaneously. They provide a statistical framework to separate intra- and in-
terindividual (between individuals) variability by using probability distributions for the
individual-specific parameters. This stands in contrast to what Sheiner and Beal (1980)
call the two stage approach to population modelling, where model parameters are esti-
mated separately for each individual.
Therefore NLME models give better estimates of the variabilities and it has been shown
that the interindividual variabilities of the parameters are better estimated for NLME
models than for two stage models (see, e.g., Olofsen et al., 2004; Sheiner and Beal, 1980,
1983; Steimer et al., 1984). Moreover, as long as the number of individuals is sufficiently
large, a smaller amount of data samples is needed for each individual in order to obtain
good estimates of population properties. This was, e.g., shown by Overgaard et al. (2005)
in a simulation study of a one-compartment pharmacokinetics model based on a single
SDE. Furthermore, Jonsson et al. (2000) show that NLME models perform better than
two stage models to detect and characterize nonlinearities in the physiological system.
NLME models are traditionally based on a function that is nonlinear in the population
(fixed effects) parameters and in the individual-specific parameters (Davidian and Giltinan,
1995). A term is also added to accommodate for noise in the measurements. Ordinary dif-
ferential equations (ODEs) are often used to represent state variables in dynamic models.
The model output may be a function of the state, time, model parameters, and a measure-
ment noise term. To accommodate for noise that is intrinsic to the system, and not only
due to measurement errors, a better approach may be to use stochastic differential equa-
tions. Such intrinsic noise may be due to true randomness in the model parameters and
state variables over time. Also in systems without intrinsic noise, stochastic differential
equations can be used to reduce model errors due to an oversimplified ODE model.
In this study compartmental models and tracer/tracee experiments are analyzed using
techniques from nonlinear mixed effects modelling. As an example we focus on a model
of leucine kinetics based on tracer/tracee data. Figure 1 shows a graphical representation
of the model. In several publications this model, or minor modifications thereof, has been
used as a part of larger models, in which the kinetics of lipoproteins in human blood
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plasma has been studied (see, e.g., Barrett et al., 2006, for a review). However, to our
knowledge, it is the first time the model is used in an NLME setting.
The evolution over time of the model state variables is described by a system of four
coupled ODEs. In this paper we also extend the ODE model with a mean-reverting
Ornstein-Uhlenbeck process to model a non-steady state concentration of free leucine in
the plasma through the experiment, which turns the system of ODEs into a system of
stochastic differential equations, SDEs. As far as we know, it is the first time this approach
is used on tracer/tracee data. Moreover we believe that there is no published material,
up to date, where NLME and SDEs are combined in such a complex model (w.r.t. the
number of model state variables and unknown parameters to estimate).
Experimental data from 19 control individuals and 15 individuals suffering from diabetes
mellitus type 2 (DM2) are used to estimate the parameters. Furthermore we investigate
if the NLME parameters can be estimated when only a subset of the data are used for
each individual. The data have earlier been analyzed in Adiels et al. (2005a,b, 2006) in a
larger ODE based compartmental model.
We are aware of only a few studies that compare the two stage and NLME approaches
for analysis of experimental data. An example is given in Olofsen et al. (2004). Therefore
one main purpose of this paper is to compare different modelling approaches, and to show
that nonlinear mixed effects models and the two stage approach give different estimates
of population parameters. We are also interested in investigating the parameter estimates
for the SDE model, and how much that model predicts the leucine level to fluctuate during
the experiment.
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Figure 1: A graphical representation of the leucine kinetics model. It was developed by Demant et al.
(1996), based on the work in Cobelli et al. (1991). Compartment 1 corresponds to the amount of free
leucine in plasma. Compartments 3 and 4 correspond to a body protein pool with leucine uptake and
slow release back to the plasma. Compartment 2 is a hepatic intracellular compartment from which
the liver is fed with leucine that is used when apolipoproteins are synthesized. The fractional transfer
coefficient between compartments j and i is denoted kij , and U1 is the continuous inflow of material
into the first compartment. A more detailed description of the model is given in Section 3.1.
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1.1 Results in summary
1.1.1 Comparison between the two stage approach and the NLME approach
In our study the NLME models predict a more homogeneous population. This re-
flects the known fact that the interindividual variability is often overestimated when
the two stage approach is used (see, e.g., Olofsen et al., 2004; Sheiner and Beal, 1980,
1983; Steimer et al., 1984). We have also observed that, for some parameters, the two
modelling approaches produced different estimates of population averages. In simulation
studies with large residual errors, Sheiner and Beal (1983) have shown that the NLME
approach produce less biased estimates of population averages.
1.1.2 Using a smaller data set for each individual
Often rich sampling of data for each individual is difficult, time consuming, or expensive.
One main advantage with NLME modelling is that information from multiple individuals
is used simultaneously. Therefore, population parameters can often be estimated when
the number of data points is small for each individual, which may be of importance in
experimental planning.
When only half of the data were used for each individual, the estimated parameters of
the ODE based NLME model, where no noise inherent to the system is modelled for,
were similar to when all data were used. For the SDE based NLME model the variability
intrinsic to the system was estimated to be zero, indicating that data need to be sufficiently
densely sampled when SDEs are used. For the two stage approach we could not estimate
the parameters for the smaller data set. Thus, for the model investigated in this study,
the data may be sampled less dense if the proposed ODE based NLME model is used in
the analysis.
1.1.3 Comparison between NLME models based on ODEs and SDEs
When all parameters were allowed to vary between individuals both the NLME models
based on ODEs and SDEs produced excellent fits to data and small correlations between
residuals were observed. The estimated parameters were similar with the two approaches,
but the interindividual variations were in general smaller for the SDE model.
The amount of free leucine in the body fluctuates over time in the SDE model. When
all individual leucine levels are normalized, by dividing with the estimated average for
that individual, the standard deviation of the leucine level is estimated to be 0.089 at
each time point. This means that, for a typical individual, the amount of free leucine is
predicted to vary with a standard deviation of 8.9% of the estimated average value, which
indicate daily variations of leucine levels.
4
1.1.4 Differences between populations
For the two groups of individuals different estimations of the population medians of the
parameters have been observed. Especially the level of free leucine was significantly higher
for the diabetic subjects than the control individuals. Also the rate parameters differed
between the two groups and the fraction of free leucine that was degraded or used for
protein synthesis per time unit is smaller for the diabetic individuals. Moreover proteolysis
is predicted to be larger for the diabetic individuals.
2 Theory and methods
In this section we use a simple one-state compartmental model to describe the theory
of compartmental models, tracer/tracee studies, and nonlinear mixed effects models. We
also describe how stochastic differential equations can be used to account for a fluctuating
tracee in the system. Moreover we discuss how to define an objective function to evaluate
how well a model output resembles data.
2.1 Compartmental models - Tracer studies
A compartment is defined as a well mixed and kinetically homogeneous amount of material
(Cobelli et al., 2000). A compartmental model describes the relation between the amount
of matter in a compartment and the fluxes of material in and out from the system, but
also fluxes between compartments (in case of multi-compartment models).
Consider the one-compartment model described in Figure 2. The influx of material into
the compartment per time unit is denoted U , the fraction of material that leaves the
compartment per time unit is denoted a, and the amount of material in the compartment
is denoted Q. A mathematical representation of the model can be expressed with an
ordinary differential equation,
dQ/dt = −aQ + U, (1)
where, in the general, representation a and U may be state and/or time dependent.
When the system is in steady state, i.e., when Q is a constant and 0 = −aQ + U ,
measurements of Q will give little information about the dynamical properties of the
system (unless a or U are known, it is then enough with only one measurement point of
✲U
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Figure 2: A graphical representation of a one-compartment model.
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Q to describe the complete system). A common way to gain more information about the
system is by tracer experiments, in which a known amount of tracer material is added
into the system. Thus, a new input signal, u = u(t), is introduced for the tracer, q, and
measurements of the tracer-to-tracee ratio, q/Q, at successive time points may be used to
get estimates of a, U , and Q. The tracer should have the same kinetic properties as the
tracee but not affect the overall system behaviour (Anderson, 1983; Cobelli et al., 2000).
Under the assumption that Q is in steady state, the model takes the form of an ODE
dq/dt = −aq + u(t) for the tracer, and the output (response) function, Y (t) = q(t)/Q.
However, measurements are usually error-prone and it is common to add a term v = v(t)
to the output function, accounting for measurement errors but also for model uncertainty
and noise effects intrinsic to the system. Measurements are performed at discrete time
points tk, k = 1, . . . , d, and the v(tk):s are often assumed to be Gaussian (with expectation
zero) and independent, i.e., v(tk) and v(tl) are independent for k 6= l. When the output
differs significantly between different time points an alternative is to assume a proportional
error model, e.g., a lognormal distribution Y (tk) =
q(tk)
Q
exp(v(tk)). Observe that, by
taking logarithms on both sides, this may be transformed to an additive noise model.
2.2 Modelling uncertainty and intrinsic system noise
Stochastic differential equations may be used to account for noise effects that are inherent
to the system and not due to measurement errors. Such effects may be caused by true
random variations in the biological process. Moreover, in many cases the systems to be
modelled are not fully understood, or too complex to be modelled exactly by systems
of ODEs. The models may then be improved by adding a system noise term (turning
the ODEs into SDEs) representing the lumped effect of all non-explicitly mechanistically
modelled effects in the system.
In a tracer/tracee model the tracee is often assumed to be constant. However, this is not
exactly true in real biological systems through the time course of an experiment, but it
may vary around a mean value Q0. This may, e.g., be modelled by the mean reverting
Ornstein-Uhlenbeck process
dQt = α(Q0 −Qt)dt+ σQ0dWt, (2)
where Wt is the standard Wiener process, σQ0 determines the magnitude of the system
noise (the reason to include Q0 here is explained in the population model below), and α is
the rate at which Qt reverts towards the mean Q0 (given in fraction of material per time
unit). In the start of the experiment we assume that Q is Gaussian with mean Q0 and
variance (σQ0)
2/(2α), which is the asymptotic mean and variance of Qt regardless of the
initial value. Then the process Qt is stationary and Gaussian with mean E(Qt) = Q0 and
covariance Cov(Qs, Qt) =
(σQ0)2
2α
e−α(t−s) for s ≤ t (Karatzas and Shreve, 1991). Thus, at
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each time point t,
Qt ∼ N
(
Q0,
(σQ0)
2
2α
)
. (3)
If there is reason to suspect that the error terms, v(tk), are not Gaussian and independent
these terms may be split into two parts, v(tk) = v1(tk) + v2(tk), where v2 is assumed to
be Gaussian and independent, representing the measurement errors, but v1 accounts for
noise intrinsic to the system and may be modelled by a stochastic differential equation,
e.g., a zero-mean Ornstein-Uhlenbeck process (Møller et al., 2010).
Other approaches to account for system noise and uncertainty are to allow other parame-
ters to vary randomly over time or to lump the noise and uncertainty into additive terms
in the right hand side of the ODEs. Assuming these additive terms to be stochastic
processes turns the ODEs into stochastic differential equations.
2.3 Nonlinear mixed effects models with stochastic differential
equations applied to tracer/tracee experiments
When time series data come from a number of individuals in a population, the model pa-
rameters are traditionally estimated separately for each individual in the studied popula-
tion (independently of population knowledge). One can then compute population averages
and other statistical properties from the parameters obtained for each individual. This
approach to population modelling is called the “two stage approach” (Sheiner and Beal,
1980) or the “standard two stage approach” (Sheiner and Beal, 1983; Steimer et al., 1984).
Another approach to model population behaviour is the statistical framework of nonlinear
mixed effects modelling. NLME models are hierarchical in structure with a clear separa-
tion of the intraindividual and interindividual variations. The interindividual differences
are characterized by individual-specific values of the parameters, for which the distribu-
tion of the population is assumed to be known. The intraindividual variation is defined
as the individual measurement errors and system noise.
In Equations (4)-(8) we use the simple one-compartment model to illustrate how NLME
models with SDEs may be constructed. It is a model where the tracee fluctuates around
a mean steady value. The interindividual variations are seen in (7) and (8), whereas the
intraindividual variations are accounted for in Equations (4) and (6). The population
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model takes the form
dQit = α(Q
i
0 −Qit)dt+ σQi0dWt, Qi(0) ∼ N
(
Qi0,
(σQi0)
2
2α
)
, (4)
dqit = (−aiqit + ui(t))dt, qi(0) = 0, (5)
Y ik = log(
qik
Qik
) + vik, (6)
ai = a exp(ηia), (7)
Qi0 = Q0 exp(η
i
Q), (8)
where i = 1, . . . , N denotes the individual, subscript k = 1, . . . , di denotes the variable
value at sample time point tk for the i:th individual, and the measurement errors, v
i
k,
are assumed to be independent and Gaussian with expectation zero and variance Sk.
The measurements have been log-transformed which results in an additive noise structure
in (6).
The initial condition of the tracee state variable in Equation (4) is the asymptotic dis-
tribution of Qit. If the tracer material is introduced into the system as a bolus input at
time zero, an impulse function can be used for the tracer input function ui(t). A mathe-
matically equivalent model would be to use ui = 0 and qi(0) = qi0, where q
i
0 is the amount
of introduced tracer material. The reason for using σQi0 as a diffusion constant in (4) is
that the level of Qit differs between individuals.
In (7) and (8) ai and Qi0 depend on the fixed effects parameters a and Q0, thought
to represent a typical individual in the population, and the individual-specific random
parameters ηi = [ηia, η
i
Q]
T . In this paper the latter are assumed to be Gaussian over the
population with expectation zero and covariance matrix Ω = diag(ω2a, ω
2
Q). Lognormal
distributions are used for ai and Qi0 mainly since it prevents parameters from being
negative, even if the interindividual variabilities are large. The parameters a and Q0 do
not represent means, but instead the medians of the lognormal distribution (Blackwood,
1992).
Note that the model defined by (4)-(8) is similar to the pharmacokinetics NLME model
with SDEs in Overgaard et al. (2005). There the plasma volume corresponds to the tracee
variable, and is assumed to be constant. Noise is added to the differential equation that
describes the kinetics of the drug, corresponding to the tracer Equation (5) in the above
model.
2.4 Approximation of the population likelihood function
For parameter estimation, we apply the maximum likelihood framework where the goal is
to find the parameter set that maximizes the likelihood function, defined as the probability
of finding the measured output for a given set of parameters. In the presentation below
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we allow for multiple measurement variables, in contrast to in (6) where we only have one
measured variable.
To construct a likelihood function we assume that the densities in the output function
are Gaussian at all time points, tk, and dependent only on the information available at
time tk−1. For k = 2, . . . , di, let Y ik−1 = [yi1, . . . , yik−1]T be the data up to time tk−1 for
individual i. Let
Y ik|k−1 = E(Y
i
k |Y ik−1) (9)
be the predicted mean value at time tk, conditioned on the information available at time
tk−1, and
Rik = R
i
k|k−1 = Cov(Y
i
k |Y ik−1), (10)
the corresponding conditional covariance matrix. Then the residual vector ǫik = y
i
k − Y ik|k−1
is Gaussian with expectation zero and covariance Rik. The starting point, (Y
i
1|0, R
i
1), for the
recursion algorithm needed to compute (9)-(10) is determined by the initial distributions
of the state variables.
Kalman filtering techniques may be used to compute ǫik and R
i
k. The Kalman filter (KF)
can be applied if the model is linear. It is optimal in the sense that it minimizes the vari-
ance of the prediction error if it is assumed that the densities of the model outputs and
the initial conditions are Gaussian, and that the covariance matrix for the Gaussian noise
in the state equations and the output noise covariance are state independent (Jazwinski,
1970). The basic idea is that at every sample the conditional distributions of the state
variables are updated by taking the new data point into account. This typically results in
a net movement from the predicted mean value of the state in the direction of the experi-
mental observations. For nonlinear models, such as the one in Equation (6), the extended
Kalman filter may be used (Kristensen et al., 2004; Overgaard et al., 2005; Jazwinski,
1970). It is based on a linearization (in each time step,tk) of the nonlinear parts of the
model, which results in approximate equations to which the KF can be applied.
The population likelihood function is a marginal likelihood function, where all the indi-
vidual parameters, ηi, are integrated out. The Gaussian densities of the residuals and
the individual-specific parameters, ηi, gives a likelihood function of the form (see, e.g.,
Overgaard et al. 2005)
L(θ;Y) =
N∏
i=1
∫
Rr
exp(li)dηi, (11)
where θ is the vector of population parameters (i.e., θ = [a,Q0, ω
2
a, ω
2
Q, σ, S]
T in model (4)-(8)),
Y = {Y1, . . . ,YN} is the complete set of measurement data. The individual log-likelihood
function li = li(ηi) = li(ηi;Y i, θ) is given by
li = −1
2
( di∑
k=1
[
ǫik
T
Rik
−1
ǫik + log |Rik|+m log(2π)
]
+ ηi
T
Ω−1ηi + log |Ω|+ r log(2π)
)
, (12)
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where m is the number of outputs and r is the number of interindividual random effects,
i.e., the dimension of ηi.
In general it is not possible to find an exact expression of the population likelihood
function for a model with SDEs. The integrand must therefore be approximated and we
have applied the Laplace approximation method together with the first-order conditional
estimation (FOCE) method (see, e.g., Overgaard et al. 2005; Wang 2007). The Laplace
approximation method is based on a second order truncation of the Taylor expansion of
li around a stationary point ηˆi. In the FOCE method ηˆi is estimated as
ηˆi = argmin
ηi
{−li(ηi;Y|θ)} , (13)
in contrast to the first order (FO) method that uses ηˆi = 0 (see, e.g., Overgaard et al.
2005, for the details). With the Laplace approximation method the population likelihood
function in (11) is approximated as
L(θ;Y) ≈
N∏
i=1
exp(li(ηˆi))
∣∣∣Hη(li(ηˆi))
(2π)r
∣∣∣−1/2, (14)
where, by disregarding second order derivatives of the residuals, ǫik, and covariance ma-
trices, Rik, the Hessian Hη(l
i(ηˆi)) is approximated as
(
Hη(l
i(ηˆi))
)
a,b
=
∂2(li(ηˆi))
∂ηa∂ηb
≈ −
di∑
k=1
∂ǫik
T
∂ηa
Rik
−1∂ǫik
∂ηb
+
di∑
k=1
(
ǫik
T
Rik
−1∂Rik
∂ηa
Rik
−1∂ǫik
∂ηb
+
∂ǫik
T
∂ηa
Rik
−1∂Rik
∂ηb
Rik
−1
ǫik
)
−
di∑
k=1
ǫik
T
Rik
−1∂Rik
∂ηa
Rik
−1∂Rik
∂ηb
Rik
−1
ǫik (15)
− 1
2
di∑
k=1
Tr
(
−Rik−1
∂Rik
∂ηa
Rik
−1∂Rik
∂ηb
)
− (Ω−1)
a,b
,
in position (a, b), a, b = 1, . . . , r. Proving (15) is elementary by using differentiation
rules for matrices found in Petersen and Pedersen (2008). Differentiation with respect
to a matrix (or vector) in (15) is performed on all elements in the matrix. If there is no
interaction between the interindividual effects, ηi, and the intraindividual variation effects,
the derivatives of Rik are zero and (Hη(l
i(ηˆi)))a,b ≈ −
∑di
k=1
∂ǫi
k
T
∂ηa
Rik
−1 ∂ǫi
k
∂ηb
− (Ω−1)a,b.
Every separate evaluation of the approximate population likelihood function requires the
estimation of the individual parameters ηi when the FOCE method is applied. This may
result in computationally heavy calculations, especially when the number, r, of interindi-
vidual effects is large.
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2.5 Implementation
All the implementations have been performed in MATLAB R© (2008b, The MathWorks,
Natick, Massachusetts, USA).
2.5.1 Optimization methods
For NLME models the population parameters are estimated as
θˆ = argmin
θ
{− log(L(θ;Y))} . (16)
To optimize (13) we have used a quasi-Newton method based on the so called BFGS (Broy-
den, Fletcher, Goldfarb, and Shanno) updating formula (Nocedal and Wright, 1999). To
find the optimal population parameters in (16) we start with the derivative free Nelder-
Mead simplex-reflection method (Nocedal and Wright, 1999) for a finite number of iter-
ations to get closer to the true optimum. Then the optimization has been fine-tuned by
the BFGS-method. The gradients used in the BFGS method have been approximated by
a finite central-difference approximation.
The Nelder-Mead simplex-reflection method and the BFGS method are both local op-
timization methods, i.e., only local minima of the objective functions are searched for.
However, for the models investigated in this paper, different initial guesses of the param-
eters always resulted in convergence to the same optimal parameter set, indicating that
the objective functions do not have multiple local minima.
The steps that we have used to estimate the parameters in the NLME settings are:
• Choose an initial guess, θ0, of the population parameters and ηi0 = 0 for the
individual parameters (i = 1 . . . , N).
• Calculate the population likelihood (14) by optimizing ηi in (13) for i = 1, . . . , N .
Let ηˆi0 denote the optimized η
i:s.
• Set j = 1 and repeat the following until a stopping criterion is reached:
- Find a new θj according to the optimization algorithm by using ηˆ
i
j−1 as initial
values in every new calculation of (14).
- Denote ηˆij the optimized η
i for θ = θj .
- Set j = j + 1.
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2.5.2 Inference on estimated parameters
For inference on the estimated parameters of an NLME model an approximation of the
covariance matrix may be obtained from
Cov(θˆ) ≈ (Hθ(− log(L(θˆ;Y))))−1 (17)
(Kristensen et al., 2004), where Hθ denotes the Hessian with respect to θ. The maximum
likelihood estimate is Gaussian and the covariance matrix is the inverse of the Fisher in-
formation matrix, which is the expected value of the Hessian of the negative log-likelihood
function when data are seen as random variables (Pawitan, 2001). For a given realization,
Y , of the data, the observed Fisher information matrix, Hθ(− log(L(θˆ;Y))), may be used
instead (Pawitan, 2001). However, in this study we only approximate the population
likelihood function in (14) and the Hessian is computed numerically by means of a central
difference procedure around the estimated parameters.
When different mathematical models are used it is interesting to test if they give sig-
nificantly different estimated values of the same physical quantities. With the NLME
approach we approximate the confidence intervals around each estimated parameter by
using (17) and assuming that θˆ is Gaussian. Confidence intervals around the estimated
population parameters can also be calculated by taking every individual into account, as
discussed in Section 3.1.1.
If the confidence intervals around a parameter are disjoint when two different models
are used, we say that the models predict the parameter differentially with statistical sig-
nificance at a certain confidence level. In a study where sample means from repeated
measurements from normally distributed data were compared, Payton et al. (2000) sug-
gest to use 85% confidence intervals to test the hypothesis that the means are equal at
significance level 0.05. We follow that suggestion when we compare the parameters of
our models, but it should be mentioned that the confidence intervals in our study are not
calculated from repeated realizations from a normal distribution.
2.5.3 The extended Kalman filter
The extended Kalman filter has been implemented as described in Kristensen et al. (2004).
The EKF needs estimates of the predicted initial state and the initial state covariance
matrix. As discussed in Section 2.2, we use V ar(Q(0)) = (σQi0)
2/(2α) as an estimate of
the variance of the tracee state variable modelled as in Equation (4). When the underlying
model is deterministic in the state variables (ODE based), the state covariance is zero.
The state equations for the models examined in this study are linear differential equations
and the only non-linear parts of the models are present in the model output equations.
Therefore the linearization approximation in the EKF is only applied to the model output
equation.
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3 Population Models of Leucine Kinetics
In this article NLME models based on ordinary and stochastic differential equations
are constructed for a compartmental model that describes the kinetics of leucine in
blood plasma. The ODE based model has been used in several publications as a sub-
model of larger compartmental models that describe the kinetics of low density lipopro-
teins in plasma, see, e.g., Adiels et al. (2005b); Demant et al. (1996), or the review in
Barrett et al. (2006). As far as we know the model parameters are estimated on single
individuals and population features have been inferred with the two stage approach in all
studies up to date.
When the leucine model has been applied to fit parameters to data from single individuals
the estimated values of the parameters vary much over the population. An explanation
for this may be that measurement errors in data are not taken care of (Olofsen et al.,
2004). One benefit with the NLME approach is that it handles intraindividual variations
explicitly. In our implementation large interindividual variations are penalized since the
individual log-likelihood in Equation (12) becomes smaller for larger absolute values of
the elements in ηi (through the term −ηiTΩ−1ηi).
A stochastic differential equation is used to account for tracee deviations from steady state
as in Equation (4). It should be pointed out that a population approach such as NLME
modelling is needed to estimate parameters in SDEs when the data are sparsely sampled
for each individual, since rich sampling is needed to separate system noise from measure-
ment noise in single subject estimation algorithms (Overgaard et al., 2005). A population
approach such as an NLME model allows for more data to be used simultaneously.
The data used are taken from experiments where stable isotope-labelled leucine (2H3-
leucine) was introduced in the system as a bolus input. The experimental setup is de-
scribed in Adiels et al. (2005a,b, 2006). The data set is divided into one group of control
individuals and one group of individuals suffering from diabetes mellitus type 2. The data
from the 19 individuals in the control group are also used in Adiels et al. (2005a,b, 2006).
The data from the 15 diabetic individuals are also used in Adiels et al. (2005a, 2006).
Each individual was fasting 12 hours prior to the tracer injection and also during the
sampling period. The samples were collected 16 times at 2, 4, 6, 8, 10, 12, 15, 20, 30,
and 45 minutes and 1, 2, 3, 4, 6, and 8 hours after the tracer injection. However there are
missing data for some individuals. The data for a single control individual is visualized
in Figure 3.
We will now describe the ODE based individual model (additive Gaussian measurement
noise) used in a two stage approach to indirectly compute population parameter properties
(Section 3.1). Then we present the ODE based NLME model (additive Gaussian mea-
surement noise, lognormal distributed population parameters) used directly to estimate
parameter values and their distributions taking a maximum likelihood approach (Sec-
tion 3.2). Thereafter the SDE based NLME model (additive system noise) is discussed
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(Section 3.3). The estimated population parameters are presented after each model has
been presented. Finally we compare the results for the NLME models based on ODEs
and SDEs (Section 3.4).
3.1 The ODE based individual model used in a two stage ap-
proach
Leucine is an essential amino acid, which means that it is not synthesized in the body
and that humans must acquire it from the diet. It is an important element in apolipopro-
tein B (apoB), and since low density lipoproteins contain exactly one apolipoprotein B-100
molecule, stable isotope-labelled leucine can be used as tracer in kinetic studies of low den-
sity lipoproteins. The model used in this article describes the kinetics of leucine in plasma
before it enters the apoB synthesis machinery in the liver. The model was developed by
Demant et al. (1996), and is based on the work in Cobelli et al. (1991). The data consist
only of measurements of free leucine in plasma and is expressed as a tracer-to-tracee mass
ratio. Figure 1 shows a schematic view of the model.
Compartment 1 corresponds to the amount of free leucine in the plasma. It has a con-
tinuous inflow of leucine from other parts of the body and also an exit (corresponding to
catabolism of leucine and uptake of leucine by body proteins with a very slow turnover
rate), described by the fractional transfer coefficient parameter k01. The amount of inflow
of unlabelled free leucine per time unit is given by the parameter U1. Since the tracer was
introduced as a bolus input all the labelled leucine is assumed to be in compartment 1
at time zero. No additional labelled leucine is assumed to be introduced into the system.
Compartments 3 and 4 correspond to a body protein pool that account for the uptake
and subsequent slow release of leucine back to the plasma. Compartment 2 is a hepatic
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Figure 3: Logarithm of the data for an individual in the control group. The output predicted by the
ODE based NLME model described in Section 3.2 is also included in the figure.
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intracellular compartment. From this compartment the liver is fed with leucine that is
used when apolipoproteins are synthesized. The parameter that describes the fraction
of material in compartment 2 that reach the apoB synthesis machinery in the liver per
time unit is here denoted kL2. When time passes the system is washed out from labelled
material and the amount of tracer in the system converges to zero. Throughout this paper
the time unit used is hours, thus all fractional transfer coefficients are presented in the
unit h−1. The amount of material in compartments is presented in mg.
The ordinary differential equations in the model of the tracee system are (Adiels et al.,
2005b; Demant et al., 1996)
dQ1/dt = −(k01 + k21 + k31)Q1 + k12Q2 + k13Q3 + U1 (18)
dQ2/dt = −(k12 + kL2)Q2 + k21Q1 (19)
dQ3/dt = −(k13 + k43)Q3 + k31Q1 + k34Q4 (20)
dQ4/dt = −k34Q4 + k43Q3, (21)
where Qj = Qj(t) is the amount of tracee material in compartment j at time t. We
assume here that the fractional transfer coefficients are not state dependent. Hence the
system is linear, and the systems for the tracer and the tracee are identical except for U1
which is controlled by the experimentalist for the tracer system (it is assumed that no
labelled material is produced in the body).
Let Q = [Q1, Q2, Q3, Q4]
T and q = [q1, q2, q3, q4]
T be state vectors for the tracee- and tracer
system respectively, and U = [U1, 0, 0, 0]
T be a vector of input variables in the tracee
system. Then the complete model can be written compactly in matrix notation as
dQ/dt = KQ+ U (22)
dq/dt = Kq (23)
Yk = q1(tk)/Q1(tk), (24)
where (22) corresponds to the tracee system, (23) to the tracer system, and (24) corre-
sponds to model output taken at discrete time points tk, k = 1, . . . , d, where d is the
number of samples. Observe that the experiments are based on a bolus injection in com-
partment 1 at time zero. It is assumed that the tracer material is instantly well stirred
throughout the plasma and that there is no tracer material in the system before the ex-
periments start, therefore q(0) = [q10, 0, 0, 0]
T , where q10 is the known amount of labelled
leucine injected (7 mg/[kg body weight] in our case). Another assumption is that the
exchange of hydrogen atoms between leucine molecules and other molecules in the body
is negligible, i.e., it is assumed that labelled leucine molecules remain labelled through-
out the experiment. The matrix K is the compartmental matrix of the system, i.e., the
coefficient matrix of the linear system (18)-(21).
The tracee system is approximated by a steady state (Adiels et al., 2005b), i.e., dQ/dt = 0
and the fractional transfer coefficients, kij, are constant. In matrix notation we get
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0 = KQ + U ⇒ U = −KQ or Q = −K−1U for the tracee equations. Compartmental ma-
trices are always invertible if there are at least one exit compartment (a compartment with
a flow out of the system) and the system contains no traps (subsystems with no flows to
the outside of the subsystem) (Cobelli et al., 2000).
When the leucine system is considered separately (without the apoB part) the fractional
rate, kL2 (per hour), of material leaving compartment 2 for lipoprotein synthesis is uniden-
tifiable and in this article it is set to 0.01h−1. This value has been chosen because
it is the value that we have found for most subjects in an implementation of the full
apoB-model. Further parameter constraints have been used to reduce the number of
unknowns. This is actually necessary to get an a priori identifiable model since, with-
out the constraints, three different parameter sets describe the same model structure
(Cobelli et al., 1980). We have followed Packard et al. (2000) and used k21 = k12 (the
rate of the flow of leucine through the cell walls of liver cells are the same in both direc-
tions) and k34 = 0.1k43. It is not necessary to estimate both U1 and Q1 separately since
U = −KQ⇒ U1 = Q1(k01(k12 + kL2) + k21kL2)/(k12 + kL2) mg/hour. Thus, the parame-
ters that are estimated for a single individual are k01, k12, k13, k31, k43, and Q1.
3.1.1 Estimated parameters
Assuming a steady state for the tracee, the parameters were estimated for each individual
separately. We used the weighted least squares method, taking the measured values as
weights at each time point.
The geometric mean and the coefficients of variation (CoV) of the full population are
presented in Table 1 for the six parameters. The reason for reporting the geometric mean
instead of the arithmetic mean is that the parameters are approximately lognormally dis-
tributed in the population. Therefore, the variations of the parameters are multiplicative.
The geometric mean is a maximum likelihood estimator of the median of a lognormal
distribution (Blackwood, 1992). The coefficient of variation of the multiplicative model is
a normalized measure of the spread of the parameters. It relates the standard deviation to
the median of the parameters and is calculated by CoV = 100×√exp(s2)− 1 %, where
s2 is the unbiased estimate of the variance of the logarithm of the estimated parameters
(Blackwood, 1992).
The parameters k12 and k13 are the ones that display the largest variation over the popula-
k01 k12 k13 k31 k43 Q1
All individuals 2.15 (41%) 1.77 (116%) 1.78 (115%) 3.48 (70%) 1.00 (63%) 373 (65%)
Controls 2.32 (32%) 1.70 (137%) 1.61 (132%) 4.18 (37%) 0.94 (53%) 289 (43%)
Diabetics 1.96 (51%) 1.86 (98%) 2.04 (95%) 2.76 (98%) 1.09 (80%) 516 (73%)
Table 1: Estimated geometric mean (and coefficient of variation) of the parameters when data from
the 34 individuals are used. The population parameters are trimmed as explained in the text.
16
tion. This is, at least partially, because the objective function is less sensitive to variations
in these parameters. Therefore they are more influenced by noise in the observations than
the other parameters. The estimated population parameters are trimmed in the sense that
a few estimates are manually removed from the calculations (e.g., k01 is estimated to be
0.001 - the predefined lower bound - for two individuals). All parameters except Q1 had
a few individual estimates that were manually removed.
To compare the results from the two stage approach with the results from the NLME ap-
proach in the forthcoming sections we calculated 85% confidence intervals for the medians
of the parameters for respective group (see Figure 4, where the corresponding intervals
for the NLME models are also included). We especially observe that, for the two stage
estimates, Q1 differs between control group 1 and the diabetic group. The confidence
intervals have been calculated as explained below.
If a parameter p is normally distributed over the population with unknown mean and
variance, a 100(1− αˆ)% confidence interval of the population mean of p can be estimated
as p¯± tαˆ/2,N−1 s√N , where p¯ is the sample mean of the N observations of p, s the (unbiased)
sample standard deviation of the observations, and tαˆ/2,N−1 is the 100(1− αˆ/2) percentile
of the t-distribution with N − 1 degrees of freedom (Larsen and Marx, 2001). However,
since the parameters are assumed to be lognormally distributed over the population we
calculated confidence intervals (a, b) for the means of the logarithms of the estimated pa-
rameters and used (ea, eb) to obtain confidence intervals of the medians of the parameters
as suggested in Blackwood (1992).
To compare the interindividual variations for the two stage approach and the NLME mod-
els in Sections 3.2 and 3.3 we have also computed confidence intervals of the population
variance of log(p˜i), where p˜i for an individual i is its actual parameter estimate pi divided
by the group geometric mean of p for that individual. The confidence interval around
a variance, σ˜2, can be calculated since (N−1)s˜
2
σ˜2
is χ2-distributed with N − 1 degrees of
freedom if the sample comes from a normal distribution (Larsen and Marx, 2001). We as-
sume that log(p˜i), i = 1, . . . , N , is normally distributed and the estimated 85% confidence
interval for the interindividual variations are presented in Figure 4.
3.2 The ODE based NLME model
Equations (22)-(24) and the above discussion lead to the following population model,
dqit/dt = K
iqit, q
i
0 = [q
i
1,0, 0, 0, 0]
T , (25)
Y ik = log(
qi1,k
Qi1
) + vik, v
i
k ∼ N(0, S), (26)
where superscript i = 1, . . . , N denotes the i:th individual. When considering one individ-
ual, this is the same model as the one developed in Section 3.1, except that an error term,
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vik, is added to the output function. The errors {vik}dik=1 are assumed to be a sequence
of independent normally distributed random variables with variance S. In this model
structure they encompass measurement errors, as well as model specification errors and
system stochasticity. When considering the whole population the main differences lie in
Ki, whose coefficients are
ki01 = (G
i
Ck
C
01 +G
i
Dk
D
01) exp(η
i
01), η
i
01 ∼ N(0, ω201), (27)
ki12 = (G
i
Ck
C
12 +G
i
Dk
D
12) exp(η
i
12), η
i
12 ∼ N(0, ω212), (28)
kiL2 = 0.01, (29)
ki21 = k
i
12, (30)
ki13 = (G
i
Ck
C
13 +G
i
Dk
D
13) exp(η
i
13), η
i
13 ∼ N(0, ω213), (31)
ki31 = (G
i
Ck
C
31 +G
i
Dk
D
31) exp(η
i
31), η
i
31 ∼ N(0, ω231), (32)
ki43 = (G
i
Ck
C
43 +G
i
Dk
D
43) exp(η
i
43), η
i
43 ∼ N(0, ω243), (33)
ki34 = 0.1k
i
43, (34)
and in Qi1, which is given by
Qi1 = (G
i
CQ
C
1 +G
i
DQ
D
1 ) exp(η
i
Q1
), ηiQ1 ∼ N(0, ω2Q1). (35)
The group index variable GiC (and G
i
D) equals one if individual i belongs to the control
group (diabetic group) and zero otherwise. The fixed effects parameters kj01, k
j
12, k
j
13, k
j
31,
kj43, and Q
j
1 are the same for all individuals in group j and represent the parameters for a
typical individual in respective group (where j is C or D). The parameters are assumed
to have a lognormal distribution in the population to avoid negative parameter values.
To sum up, the unknown population parameters that may be estimated in the ODE
based NLME framework are: the structural population fixed effects parameters kj01, k
j
12,
kj13, k
j
31, k
j
43, and Q
j
1 (for j = C,D), the variances ω
2
01, ω
2
12, ω
2
13, ω
2
31, ω
2
43, and ω
2
Q1
of
the interindividual variation, and the variance S of the measurement error term. Observe
that we assume that the interindividual and the intraindividual variations are the same
for the two groups in this model.
The results from the two stage approach is used as an initial guess of the structural
parameters. The initial guess for S was obtained by first estimating S alone, with all the
other parameters kept fixed to their initial values.
3.2.1 Estimated parameters
Table 2 shows the estimated parameters and standard errors (SEs) for the ODE model
(25)-(35) applied to the experimental data (the estimated parameters from the SDE model
explained in the next section are also included in the table). Observe that the uncertainties
of the ω-parameters are large compared to the estimated values.
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In addition to estimating the parameters using all experimental data, we also estimated
the parameters using a smaller set of data, in which the data points at 4, 8, 10, 15,
and 45 minutes and 3, 6, and 8 hours were removed. Thus, at most eight samples per
individual were used for the smaller set. The reason for estimating the parameters for a
smaller data set was to test if population parameters can be reliably estimated even if
the number of samples in the time series is low for each separate individual. It should
be mentioned that the two stage approach was also applied to the smaller data set. In
that case the spread of the estimated parameters was much larger between individuals
compared to when all data were used and at least one parameter reached the predefined
lower- or upper bounds for most individuals.
In Table 2 and Figure 4 it can be seen that using at most eight samples per individual
gave no disjoint 85% confidence intervals compared to when all data were used (we used
the standard errors of the estimated parameters to obtain confidence intervals for the
NLME model). Most parameters are also very similar in general, but the estimates of
ω212, ω
2
31, and ω
2
43 deviates rather much for the two data sets and the overlapping confidence
intervals are due to large uncertainties of the estimates. The estimated standard errors of
the average parameters and the intraindividual noise parameter, S, were in general higher
when only half the data set was used, indicating more uncertain parameter estimates.
We were also interested in comparing the estimated population parameters from the two
ODE - all data ODE - less data SDE - all data
Controls Diabetics Controls Diabetics Controls Diabetics
k01 2.58 (0.13) 2.08 (0.12) 2.60 (0.13) 2.05 (0.13) 2.64 (0.14) 2.06 (0.12)
k12 1.75 (0.16) 1.69 (0.20) 1.51 (0.27) 1.78 (0.22) 1.61 (0.16) 1.56 (0.20)
k13 3.74 (0.54) 5.47 (0.95) 3.95 (0.57) 4.93 (1.11) 4.00 (0.50) 4.82 (0.76)
k31 3.96 (0.39) 3.40 (0.44) 4.24 (0.44) 2.88 (0.51) 4.34 (0.48) 3.32 (0.47)
k43 1.22 (0.17) 1.38 (0.26) 1.06 (0.23) 1.54 (0.34) 1.16 (0.14) 1.27 (0.22)
Q1 297 (28) 558 (59) 296 (29) 571 (64) 290 (27) 555 (59)
ω201 0.044 (0.012) 0.040 (0.011) 0.044 (0.013)
ω212 0.083 (0.034) 0.015 (0.023) 0.041 (0.034)
ω213 0.258 (0.089) 0.199 (0.098) 0.073 (0.059)
ω231 0.044 (0.040) 0.024 (0.031) 0.079 (0.043)
ω243 0.296 (0.095) 0.128 (0.071) 0.203 (0.068)
ω2Q1 0.161 (0.040) 0.173 (0.043) 0.158 (0.041)
S 4.34 · 10−3 (0.38 · 10−3) 4.89 · 10−3 (0.74 · 10−3) 6.98 · 10−4 (2.61 · 10−4)
α — — 3.09 (0.95)
σ — — 0.222 (0.027)
Table 2: Estimated parameters (and standard errors of the estimates) for the NLME model explained
in equations (27)-(35). In the left panel the parameters of the ODE model (25)-(26) are presented
when all experimental data were used. In the middle the estimated parameters are presented when
the samples at 4, 8, 10, 15, and 45 minutes and 3, 6, and 8 hours were removed. The right panel
consists of the corresponding estimated parameters, together with the parameters α and σ, when the
SDE model (36)-(38) was applied to all data.
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stage approach with the results from the NLME approach when all data were used. As
can be seen in Figure 4 some estimated values differ between the two approaches, and
the estimated medians kC13, and k
D
13 have disjoint 85% confidence intervals. Moreover,
all the interindividual variances are estimated to be smaller for the NLME model and
ω201, ω
2
12, ω
2
13, and ω
2
01 are smaller with statistical significance.
Observe that the estimated population parameters for the two stage approach in Sec-
tion 3.1.1 were trimmed (by removing estimates of parameters significantly different from
most other individuals) before computing population averages and variations of the pa-
rameters. If all estimated parameters are accounted for in that case the interindividual
differences are even larger. Then the NLME approach predicts a significantly smaller
interindividual variation also for k43.
0
2
4
6
8
10
10ω
2
01
10ω
2
12
10ω
2
13
10ω
2
31
10ω
2
43
10ω
2
Q1
Estimated interindividual variability
0
2
4
6
8
Estimated medians
 
 
k
C
01
k
D
01
k
C
12
k
D
12
k
C
13
k
D
13
k
C
31
k
D
31
k
C
43
k
D
43
QC
1
100
QD
1
100
Two stage, all data
ODE model, all data
ODE model, half data
SDE model, all data
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are 13.0 and
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the SDE based NLME model applied to all data.
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With the two stage approach we discovered that Q1 differed between the groups. For the
ODE based NLME model we see that there are significant differences for k01 and Q1.
It is worth mentioning that the confidence intervals for the population parameters of the
lognormal distributions in the NLME model may be calculated as in Section 3.1.1, by
taking every individual into account. Doing so, the 85% intervals were in general more
narrow compared to using the “standard error approach” and, in addition to k01 and
Q1, also k13 and k31 have disjoint confidence intervals between the groups. Thus, when
confidence intervals of the medians of the population parameters are computed by taking
every individual into account, we conclude that both the leucine levels in the plasma and
leucine kinetics differ between control individuals and individuals suffering from diabetes
type 2.
3.3 The SDE based NLME model
We extend the ODE model by assuming that the tracee in compartment 1 is fluctuating
around a steady state value. The state variable Qi1,t is modelled with a mean-reverting
Ornstein-Uhlenbeck process as discussed in Section 2.3 for a one-state compartmental
model. The reason for testing the model under this assumption is that the amount of
amino acid material is probably not exactly constant in the body, but varies over time.
Daily rhythms of leucine levels have also earlier been reported (see, e.g., Lavie and Lavie
2006).
The SDE model takes the form
dQi1,t = α(Q
i
1,0 −Qi1,t)dt + σQi1,0dWt, Qi1(0) ∼ N
(
Qi1,0,
(σQi1,0)
2
2α
)
, (36)
dqit = (K
iqit)dt, q
i(0) = [qi1,0, 0, 0, 0]
T , (37)
Y ik = log(
qi1,k
Qi1,k
) + vik, v
i
k ∼ N(0, S), (38)
where Qi1,0 corresponds to Q
i
1 in Section 3.2. Thus, compared to the ODE model, two
new parameters, α and σ, must be estimated.
3.3.1 Estimated parameters
When using the smaller set of data, the estimate of σ converged to zero, and the SDE
model was reduced to the ODE model. Therefore we only present the parameter estimates
when the model was used on the complete data set.
Overall, the SDE model produced similar parameter estimates as the ODE model (see
Table 2 and Figure 4). However, ω212, ω
2
13, ω
2
31, and S deviate quite much, but only S have
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overlapping confidence intervals. Interestingly, the parameters that describe interindivid-
ual variability are, in general, smaller than for the ODE model.
Like the ODE based NLME model, the SDE model predicts group differences for k01 and
Q1 when the “standard error” approach was used to compute confidence intervals and for
k01, k13, k31, and Q1 when all individual estimates were used.
We observed strong correlations between the parameters describing the intraindividual
variations of the model. The estimated correlations were 0.79 between α and σ, −0.40
between α and S, and −0.69 between σ and S.
3.4 Comparison between ODE and SDE results
Both the ODE- and SDE based NLME models gave good fits to data (see the upper
plots in Figure 5) and small correlations between residuals (when SDEs are used the
term residual refers to the observed data point subtracted by the one step prediction
obtained from the extended Kalman filter at the given time point). The difference between
the two approaches is that the SDE model predicts a varying leucine level. Let zit =
Qi1,t/Q
i
1,0 be the normalized process described by dz
i
t = α(1− zit)dt+ σdWt. Then zit has
variance σ2/(2α), thus the leucine level is predicted to vary with a standard deviation of
100× σ/√2α percent of the predicted average value. With the estimated values of σ and
α we get a standard deviation of 0.089.
In Figure 6 we visualize how the level of free leucine in the body changes in the extended
Kalman filter for a single individual. First the model predicts the level to be at the mean
level. Then an update is performed at the first measurement time point and the model
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Figure 5: The residuals for all 34 individuals at the sixteen sampled time points. The lines correspond
to mean values. In the lower plots the reduced models described in Section 3.4.1 are used.
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makes a new prediction at the next time point, given the previous update. The procedure
is then iterated until the last time point is reached. Observe that we at the x-axis have the
index of each time point, not the actual times. In the plot the leucine level is normalized
as described above.
In the output functions, (26) and (38), it is assumed that the errors vik are Gaussian and
independent. The first assumption has been tested by applying the Lilliefors test function
lillietest in MATLAB to the residuals. With significance level 0.05 an assumption about
normality can be rejected for four individuals for the ODE model and one individual
for the SDE model (in these individuals we observed one or two residuals significantly
different from the other, indicating outlying observations).
One way to investigate the independence assumption is by means of the autocorrelations
between the residuals (one step prediction errors). That was also done in Møller et al.
(2010) and Overgaard et al. (2007), where they concluded that the residual correlations
decreased for their proposed SDE models.
However, the autocorrelation of the residuals does not give any information about corre-
lations between specific sample points, but is more a general representation of the correla-
tions for specific lags. When analyzing multiple individuals sampled at the same times we
can instead compute the sample correlations of the residuals for specific time points (the
correlation between residuals at time tj and tk is calculated as rjk =
∑N
i=1
(ǫij−ǫ¯j)(ǫik−ǫ¯k)
(N−1)sjsk ,
where ǫ¯k is the mean of all the residuals at time tk, and sk is the sample standard devia-
tion). This gives a more detailed representation of the residual correlation structure. For
0 2 4 6 8 10 12 14 16
0.85
0.9
0.95
1
1.05
1.1
Index of time point
No
rm
aliz
ed
 le
uc
ine
 le
ve
l
Normalized leucine level in the EKF for individual 1 in the control group
Figure 6: The normalized free leucine level in the EKF for an individual in the control group. The
dashed lines indicate 1 ± 0.089, i.e., the mean plus/minus the standard deviation of the process at
each time point. For this individual there is a missing data point at 8 hours, i.e., the data are taken at
2, 4, 6, 8, 10, 12, 15, 20, 30, and 45 minutes and 1, 2, 3, 4, and 6 hours. Observe that when the
interval between measurements increase, the jumps away from the mean becomes longer, indicating an
increase in the uncertainty of the state.
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the NLME models presented in Sections 3.2 and 3.3 the correlations between the residuals
are small. A correlation matrix for the residuals from the ODE model is presented in the
left hand plot in Figure 7.
3.4.1 Reduced ODE- and SDE based models
If an ODE based model is less accurate it may produce subsequent over- or underpre-
dictions of the data, thus producing correlated residuals. A method to reduce these
correlations may be to introduce system noise by means of SDEs in the model. Since
the ODE model described above seems to produce good fits to data we have investigated
this for a reduced version of the leucine model where ω12 and ω13 were fixed to zero (the
reason to choose these parameters is that a sensitivity analysis indicate that k12 and k13
have the least influence on the objective function). We call the new models the reduced
ODE- and SDE models, respectively.
The sample correlation matrices for the residuals of the reduced models are also presented
in Figure 7. We observe that the residuals are less correlated for the SDE model. The
most striking difference between the two models is that the correlations between adjacent
residuals are in general positive for the ODE model but not for the SDE model. The
conclusion to be drawn from this is that the SDE model well captures the involved mech-
anisms and that the remaining noise and uncertainty can be described well by normally
distributed random variables and Wiener processes.
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Figure 7: Correlation matrices for the residuals for the ODE based NLME model where all parameters
vary between individuals, and the reduced ODE- and SDE models respectively. Only the correlations
significantly different from zero (p < 0.05) are highlighted and correlations with p > 0.05 are set to
zero. The p-values are calculated by testing the hypothesis that the correlation rjk is zero against the
alternative rjk 6= 0 as explained in Larsen and Marx (2001).
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4 Discussion
In this article population models for leucine kinetics in blood plasma have been proposed.
The models are based on differential equations to account for the dynamic behaviour of
leucine molecules. The first models are based on ordinary differential equations where the
tracee material is assumed to be in a steady state. The NLME model is then extended
so that the amount of tracee material is modelled by an Ornstein-Uhlenbeck process to
account for fluctuating tracee material.
The estimated population average parameters did in general not change much when SDEs
were used instead of ODEs in the NLME settings, but the interindividual variabilities were
in general estimated to be smaller for the SDE model. In systems where the tracee level
fluctuates much around a steady state during the time of the experiments, we believe
that errors in the estimated physiological parameters may occur if the fluctuations are
not accounted for in the model. We have performed simulation studies for the one-
compartment SDE model (4)-(8) that supports this hypothesis. Especially the parameters
that describe the interindividual variability tend to be overestimated when an ODE based
model is used for data generated from the SDE model.
For the constrained model (ω12 = ω13 = 0) the residuals were correlated when ODEs were
used. Correlations between the residuals indicate that the assumption that the errors
vk and vl are independent when k 6= l is incorrect. For the constrained SDE model the
correlations were smaller. This explains how SDE may be used as a tool to handle non-
explicitly modelled effects in the system. For the present leucine kinetics model there
is no obvious reason not to use the unconstrained model, but it should be mentioned
that this model requires two more parameters to be estimated for each individual and
the computational time needed to estimate the parameters with the unconstrained model
increased significantly. For larger models it may be computationally too demanding to
estimate all the parameters for each individual.
Other SDE models may be used to describe the system. One approach, that was recently
used by Møller et al. (2010), is to add a zero-mean Ornstein-Uhlenbeck process to the
model output to allow for a more flexible model output structure. We have tested that
approach and the results indicate that such a model may equally well be used to describe
the system. However, that model does not have a direct physiological description and we
decided to only present the results for the variable tracee model.
The parameters of the ODE based NLME model were also estimated using half the data
for each individual, and the results were similar to the ones obtained using all data. This
indicates that the number of samples needed per individual does not necessarily have to
be large for the ODE based NLME model. This may be of importance in experimental
planning since taking many repeated measurements may be expensive or troublesome.
The SDEmodel could not be applied when the smaller data set was used, since σ converged
to zero in that case, resulting in the ODE model. Thus, when the EKF is applied to the
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SDE based leucine kinetics model, the number of data points per individuals needs to be
sufficiently large. Overgaard et al. (2005) show that, when the number of individuals is
large, only three samples per individual are enough to estimate parameters for a simple
one-compartment SDE model. Further studies are needed to investigate the number of
individuals and data points per individual that is needed to estimate the parameters for
our model. Of particular interest is to investigate the model performance for only a few
data points per individual. To capture the dynamical behaviour, it is then important that
the measurements are not taken at the same time points for each individual.
Differences were observed when the estimated parameters from the two stage approach
were compared to the results from the NLME models. Population median estimates dif-
fered for some parameters but especially the interindividual variations were estimated
to be much smaller for the NLME models. It has earlier been observed that, for some
models, the two stage approach produce biased average parameters (see, e.g., the work
by Sheiner and Beal 1983). That the interindividual variation is overestimated with the
two stage approach has earlier been observed in a large number of publications, e.g.,
in Olofsen et al. (2004); Sheiner and Beal (1980, 1983); Steimer et al. (1984). One ex-
planation why the two stage approach seems to produce biased estimates of population
parameters is that the variance of the average parameters depend both on intra- and in-
terindividual variations. This is shown in Olofsen et al. (2004) for a simple linear model.
NLME models separate these two kinds of variations.
We have investigated the model parameters for two groups of individuals, one group
of diabetic individuals and one control group. The estimated average behaviour of the
parameters differs between the groups, and especially Q1 is much larger for the diabetic
group. Larger levels of free leucine for diabetic individuals have been reported earlier and
the amount of leucine is associated with the level of insulin treatment and magnitude of
hyperglycemia for the individuals (Gougeon et al., 2008). Moreover leucine degradation
and protein uptake of free leucine (k01 and k31) is smaller for the diabetic group and leucine
production due to increased proteolysis is larger. These findings are also in agreement to
what has been reported earlier (Gougeon et al., 2008).
There are also other physiological differences between the groups (age, body weight, level
of obesity, etc.) that may influence the parameters and a thorough investigation how such
covariates associates with model parameters is a topic of further research. Such knowledge
is important when NLME results are used in predictive studies and when parameters
are estimated for single individuals, especially when data are very sparse. The NLME
framework can then be used by simply maximizing the individual loglikelihood (12) with
all the population parameters fixed to results from earlier population studies. Note that
predictions of individual parameters can then be performed for very few data points (even
a single data point) but the predictive performance obviously increase for individuals that
have been densely sampled.
To analyze the identifiability of the model parameters we have performed studies where
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data were simulated for a given set of parameters. Given the simulated data we estimated
the parameters and they were in general similar to the true parameters, except that α
and σ were somewhat overestimated.
It would be interesting to apply other filters, which are adapted to nonlinear models.
However, in this particular model it is only the output function that is nonlinear, and we
believe that the EKF is a good choice.
The use of nonlinear mixed effects models were originally used in the area of pharmacoki-
netics and pharmacodynamics. Recently the number of applications has been growing
and the present paper is a first step towards larger NLME models in the metabolic arena,
focusing on studying lipoprotein kinetics. Using SDEs may be a good way to account for
model approximations and/or true variations of model state variables and parameters.
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